cobas Influenza A/B & RSV nucleic acid test for use on the cobas Liat System
K-Number: K213822 · 2022-07-06
Device Summary
Frequently Asked Questions
What is the cobas Influenza A/B & RSV nucleic acid test for use on the cobas Liat System?
cobas Influenza A/B & RSV nucleic acid test for use on the cobas Liat System is a medical device that received FDA 510(k) clearance on 2022-07-06. It is manufactured by Roche Molecular Systems, Inc.. The 510(k) number is K213822.
When was cobas Influenza A/B & RSV nucleic acid test for use on the cobas Liat System approved by the FDA?
cobas Influenza A/B & RSV nucleic acid test for use on the cobas Liat System received FDA 510(k) clearance on 2022-07-06, under approval number K213822.
What company makes cobas Influenza A/B & RSV nucleic acid test for use on the cobas Liat System?
cobas Influenza A/B & RSV nucleic acid test for use on the cobas Liat System is manufactured by Roche Molecular Systems, Inc..
What is the FDA product code for cobas Influenza A/B & RSV nucleic acid test for use on the cobas Liat System?
The FDA product code for cobas Influenza A/B & RSV nucleic acid test for use on the cobas Liat System is OCC.
Related Clinical Trials
Other Devices by Roche Molecular Systems, Inc.
Related Devices (Code: OCC)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.